期刊文献+

胰腺癌综合治疗现状及其价值 被引量:9

The current status and evaluation of comprehensive therapy of pancreatic carcinoma
下载PDF
导出
摘要 任何单一疗法治疗胰腺癌都难以获得理想的疗效。目前,可切除胰腺癌的治疗仍以根治性切除为主。放射治疗与手术联合应用,可提高手术切除率,减少肿瘤扩散;术中放疗可以缓解疼痛,提高生存率;对术后辅助放化疗的作用仍有争议。区域性化疗理论上有诸多优势,但仍需数据支持。物理治疗和生物治疗在胰腺癌的治疗中也已经得到广泛的重视。但只有建立以手术切除为主,联合放疗、化疗、物理及生物治疗的综合治疗体系,才有可能根本改变治疗现状,显著提高长期生存率,并改善生活质量。介入治疗作为重要的姑息治疗方法之一,近年来得到了长足的发展。 The incidence of pancreatic carcinoma is increasing obviously in recent years with a serious threat to the people's life, and yet there is not a single treatment for obtaining satisfactory prognosis. At present, the radical resection is the primary method for resectable pancreatic carcinoma, together with radiotherapy can improve the surgical resection rate and reduce the dissemination of tumors. Intraoperative radiotherapy can alleviate the pain and increase the survival rate, but the role of postoperative radiotherapy and chemotherapy is still in controversial. There is a lot of advantages for regional chemotherapy theoretically, but lack of evidence in practice. Physical therapy and biological therapy in the treatment of pancreatic carcinoma have been recognized extensively. It is possible to change fundamentally the current status of treatment and to improve the long-term survival rates with the quality of life until establishing a comprehensive treatment system mainly depended on surgical resection with combination of radiotherapy, chemotherapy, physical and biological treatment. The interventional therapy has been significantly developed as an important palliative treatment during recent years.
出处 《介入放射学杂志》 CSCD 2008年第6期451-455,共5页 Journal of Interventional Radiology
关键词 胰腺癌 综合治疗 Pancreatic Carcinoma Muhimodality treatment
  • 相关文献

参考文献4

二级参考文献24

  • 1钟守先.积极开展胰头癌根治术——为提高五年生存率而努力[J].中华肝胆外科杂志,1998,4(5):267-268. 被引量:14
  • 2徐勇.Meta分析常见资料类型及统计分析方法[J].中华预防医学杂志,1994,28(5):303-307. 被引量:66
  • 3Kornek GV, Schratter-Sehn A, Marczell A, et al. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Br J Cancer, 2000,82:98-103.
  • 4Kornek GV, Potter R, Selzer E, et al. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. Int J Radiat Oncol Biol Phys, 2001,49:665-671.
  • 5Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: T
  • 6Peretz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int J Radiat Oncol Biol Phys, 1989,17:931-935.
  • 7Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 1997,15:2403-2413.
  • 8Shewach DS, Lawrence TS. Radiosensitization of human solid tumor cell lines with gemcitabine. Semin Oncol, 1996,23(5 Suppl 10):65-71.
  • 9Glass GV. Primary,secondary and Meta - analysis of research[J].Educa Res,1976,6(1):3 - 12.
  • 10Burris HA Ⅲ, Moore M J, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first - line therapy for patients with advanced pancreatic cancer:a randomized trial[J]. Clin Oncol,1997,15(5):2403 - 2408.

共引文献138

同被引文献86

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部